4//SEC Filing
Glover Nicholas 4
Accession 0001209191-20-013404
CIK 0001290149other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:14 PM ET
Size
5.7 KB
Accession
0001209191-20-013404
Insider Transaction Report
Form 4
Glover Nicholas
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2020-02-25+359,158→ 359,158 totalExercise: $13.31Exp: 2030-02-25→ Common Stock (359,158 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the total shares on February 25, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 25, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Sierra Oncology, Inc.
CIK 0001290149
Entity typeother
Related Parties
1- filerCIK 0001578888
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:14 PM ET
- Size
- 5.7 KB